Andrew J.S. Coats

166.9k total citations · 25 hit papers
660 papers, 54.4k citations indexed

About

Andrew J.S. Coats is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Physiology. According to data from OpenAlex, Andrew J.S. Coats has authored 660 papers receiving a total of 54.4k indexed citations (citations by other indexed papers that have themselves been cited), including 516 papers in Cardiology and Cardiovascular Medicine, 179 papers in Complementary and alternative medicine and 75 papers in Physiology. Recurrent topics in Andrew J.S. Coats's work include Heart Failure Treatment and Management (259 papers), Cardiovascular Function and Risk Factors (203 papers) and Cardiovascular and exercise physiology (177 papers). Andrew J.S. Coats is often cited by papers focused on Heart Failure Treatment and Management (259 papers), Cardiovascular Function and Risk Factors (203 papers) and Cardiovascular and exercise physiology (177 papers). Andrew J.S. Coats collaborates with scholars based in United Kingdom, United States and Italy. Andrew J.S. Coats's co-authors include Stefan D. Anker, Massimo Piepoli, Philip A. Poole‐Wilson, Piotr Ponikowski, Michael B. Fowler, Tuan Peng Chua, Stefan D. Anker, Dárrel P. Francis, Andrew L. Clark and Petar Seferović and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Andrew J.S. Coats

639 papers receiving 52.4k citations

Hit Papers

Corrigendu... 1992 2026 2003 2014 2021 2001 2022 2001 2005 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.
    2021 5.8k citations Andrew J.S. Coats, Giuseppe Rosano et al. profile →
  2. Effect of Carvedilol on Survival in Severe Chronic Heart Failure
    2001 2.2k citations Andrew J.S. Coats et al. profile →
  3. Global burden of heart failure: a comprehensive and updated review of epidemiology
    2022 1.5k citations Gianluigi Savarese, Lars H. Lund et al. profile →
  4. Effect of carvedilol on survival in severe chronic heart failure
    2001 1.3k citations Andrew J.S. Coats et al. profile →
  5. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
    2005 1.1k citations Marcus Flather, Marcelo C. Shibata et al. European Heart Journal profile →
  6. Wasting as independent risk factor for mortality in chronic heart failure
    1997 1.1k citations Stefan D. Anker, Piotr Ponikowski et al. profile →
  7. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure
    2002 928 citations Andrew J.S. Coats et al. profile →
  8. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium-Enhanced Cardiovascular Magnetic Resonance
    2003 806 citations Andrew J.S. Coats et al. profile →
  9. Controlled trial of physical training in chronic heart failure. Exercise performance, hemodynamics, ventilation, and autonomic function.
    1992 746 citations Andrew J.S. Coats, Stamatis Adamopoulos et al. profile →
  10. Endotoxin and immune activation in chronic heart failure: a prospective cohort study
    1999 686 citations Josef Niebauer, Hans‐Dieter Volk et al. profile →
  11. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)
    2004 676 citations Massimo Piepoli, Constantinos H. Davos et al. BMJ profile →
  12. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure
    2000 673 citations Mathias Rauchhaus, Wolfram Doehner et al. profile →
  13. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
    1997 667 citations Andrew J.S. Coats, Philip A. Poole‐Wilson et al. profile →
  14. Hormonal Changes and Catabolic/Anabolic Imbalance in Chronic Heart Failure and Their Importance for Cardiac Cachexia
    1997 641 citations Stefan D. Anker, Piotr Ponikowski et al. profile →
  15. The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology
    2019 628 citations Alexandre Mebazaa, Marco Metra et al. European Journal of Heart Failure profile →
  16. Epidemiology and One-Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid-Range and Reduced Ejection Fraction: An Analysis of The ESC Heart Failure Long-Term Registry
    2017 588 citations Ovidiu Chioncel, Petar Seferović et al. European Journal of Heart Failure profile →
  17. Ethics in the authorship and publishing of scientific articles
    2010 545 citations Andrew J.S. Coats et al. profile →
  18. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
    2003 531 citations Stefan D. Anker, Abdissa Negassa et al. profile →
  19. Universal Definition and Classification of Heart Failure
    2021 511 citations Andrew J.S. Coats et al. profile →
  20. Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
    2019 464 citations Rudolf A. de Boer, Andrew J.S. Coats et al. European Journal of Heart Failure profile →
  21. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis
    2014 363 citations Luís Manzano, Andrew J.S. Coats et al. profile →
  22. Exercise-based cardiac rehabilitation for adults with heart failure
    2019 353 citations Edward J. Davies, Andrew J.S. Coats et al. profile →
  23. Clinical Phenotypes and Outcome of Patients Hospitalized for Acute Heart Failure: The ESC Heart Failure Long-Term Registry
    2017 321 citations Ovidiu Chioncel, Alexandre Mebazaa et al. European Journal of Heart Failure profile →
  24. Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
    2020 227 citations Marco Metra, Alexandre Mebazaa et al. European Journal of Heart Failure profile →
  25. The Heart Failure Association Atlas : Heart Failure Epidemiology and Management Statistics 2019
    2021 165 citations Petar Seferović, Aldo P. Maggioni et al. European Journal of Heart Failure profile →

Peers

Andrew J.S. Coats
Comparison fields: 5 of 192
  • Cardiology and Cardiovascular Medicine 40.4k
  • Complementary and alternative medicine 9.1k
  • Surgery 7.2k
  • Physiology 6.7k
  • Pulmonary and Respiratory Medicine 6.4k
Replace Giuseppe Mancia with:
Giuseppe Mancia Italy
Piotr Ponikowski Poland
Dalane W. Kitzman United States
Jay N. Cohn United States
Milton Packer United States
Martin G. Larson United States
William T. Abraham United States
Stefan D. Anker Germany
Margaret M. Redfield United States
Gianfranco Parati Italy
Giuseppe Mancia Italy View profile →
Citations per field, relative to Andrew J.S. Coats
Andrew J.S. Coats · 1×
Citations per year, relative to Andrew J.S. Coats
Andrew J.S. Coats · 1×

Countries citing papers authored by Andrew J.S. Coats

Since Specialization
Citations

This map shows the geographic impact of Andrew J.S. Coats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew J.S. Coats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew J.S. Coats more than expected).

Fields of papers citing papers by Andrew J.S. Coats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew J.S. Coats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew J.S. Coats. The network helps show where Andrew J.S. Coats may publish in the future.

Co-authorship network of co-authors of Andrew J.S. Coats

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew J.S. Coats. A scholar is included among the top collaborators of Andrew J.S. Coats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew J.S. Coats. Andrew J.S. Coats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Cachexia and Wasting in Chronic Illness: Regulatory and Clinical Trial Update
2025 ·Journal of Cachexia Sarcopenia and Muscle ·Francesco Fioretti, Stephan von Haehling, Andrew J.S. Coats, Javed Butler, Egidio Del Fabbro, Richard J.E. Skipworth, Barry Laird, Stefan D. Anker
0
2
Survey on the knowledge and practices in anorexia of aging diagnosis and management in Japan
2024 ·Journal of Cachexia Sarcopenia and Muscle ·Sahoko Takagi, Shosuke Satake, Ken Sugimoto, Masafumi Kuzuya, Masahiro Akishita, Hidenori Arai, Ivan Aprahamian, Andrew J.S. Coats, (unknown), Stefan D. Anker, Hidetaka Wakabayashi
1
3
Autonomic and Respiratory Consequences of Altered Chemoreflex Function: Clinical and Therapeutic Implications in Cardiovascular Diseases
2023 ·European Journal of Heart Failure ·Alberto Giannoni, Chiara Borrelli, Francesco Gentile, Paolo Sciarrone, (unknown), Massimo Piepoli, George B. Richerson, John S. Floras, Andrew J.S. Coats, Shahrokh Javaheri, Michele Emdin, Claudio Passino
17
4
Decongestion Strategies In Patients Presenting with Acutely Decompensated Heart Failure: A Worldwide Survey Among Physicians
2023 ·European Journal of Heart Failure ·Ali Vazir, Chris J. Kapelios, (unknown), Marco Metra, Yu. M. Lopatin, Petar Seferović, (unknown), Gerasimos Filippatos, Giuseppe Rosano, Andrew J.S. Coats, Ovidiu Chioncel
5
5
Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry
2023 ·European Journal of Preventive Cardiology ·Ovidiu Chioncel, Lina Benson, María G. Crespo‐Leiro, Stefan D. Anker, Andrew J.S. Coats, Gerasimos Filippatos, Theresa A. McDonagh, (unknown), Alexandre Mebazaa, Marco Metra, Massimo Piepoli, Marianna Adamo, Giuseppe Rosano, Frank Ruschitzka, Gianluigi Savarese, Petar Seferović, Maurizio Volterrani, Roberto Ferrari, Aldo P. Maggioni, Lars H. Lund
17
6
Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases
2022 ·European Journal of Heart Failure ·Bettina Heidecker, Noa Dagan, Ran D. Balicer, Urs Eriksson, Giuseppe Rosano, Andrew J.S. Coats, Carsten Tschöpe, Sebastian Kelle, Gregory A. Poland, Andrea Frustaci, Karin Klingel, Pilar Martı́n, Joshua M. Hare, Leslie T. Cooper, Antonis Pantazis, Massimo Imazio, Sanjay Prasad, Thomas F. Lüscher
84
7
Consensus statement on the current pharmacological prevention and management of heart failure
2022 ·The Medical Journal of Australia ·Andrew Sindone, Carmine G. De Pasquale, John Amerena, (unknown), (unknown), Andrew J.S. Coats, David L. Hare, Peter S. Macdonald, Aaron L. Sverdlov, J. Atherton
23
8
Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure
2022 ·European Heart Journal ·Petar Seferović, Giuseppe Rosano, Panos E. Vardas, Ivan Milinković, Marija Polovina, Adam Timmis, Andrew J.S. Coats
3
9
Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry
2021 ·European Journal of Internal Medicine ·Giuseppe Ambrosio, (unknown), Lars H. Lund, Stefano Coiro, (unknown), Gerasimos Filippatos, Roberto Ferrari, Massimo Piepoli, Andrew J.S. Coats, Stefan D. Anker, Cécile Laroche, Luis Almenar‐Bonet, Pentti Põder, (unknown), Anna Frisinghelli, Aldo P. Maggioni
23
10
Influence of Systolic Blood Pressure on Clinical Outcomes in Elderly Heart Failure Patients Treated with Nebivolol: Data from the SENIORS Trial
2014 ·European Journal of Heart Failure ·Manuel Montero-Pérez-Barquero, Marcus Flather, Sy Ha, Andrew J.S. Coats, Michael Böhm, Dirk J. van Veldhuisen, Daphne Babalis, Alain Cohen Solal, Luís Manzano
22
11
Cardiopulmonary Exercise Testing in Systolic Heart Failure in 2014: The Evolving Prognostic Role
2014 ·European Journal of Heart Failure ·Ugo Corrà, Massimo Piepoli, Stamatis Adamopoulos, Piergiuseppe Agostoni, Andrew J.S. Coats, Viviane M. Conraads, Ekaterini Lambrinou, Burkert Pieske, Ewa Piotrowicz, Jean‐Paul Schmid, Petar Seferović, Stefan D. Anker, Gerasimos Filippatos, Piotr Ponikowski
70
12
Effect of Nebivolol on Outcome in Elderly Patients with Heart Failure and Atrial Fibrillation: Insights from SENIORS
2012 ·European Journal of Heart Failure ·Bart A. Mulder, Dirk J. van Veldhuisen, Harry J.G.M. Crijns, Michael Böhm, Alain Cohen‐Solal, Daphne Babalis, Sy Ha, Marcus Flather, Andrew J.S. Coats, Isabelle C. Van Gelder
51
13
Anaemia Among Patients with Heart Failure and Preserved or Reduced Ejection Fraction: Results from the SENIORS Study
2011 ·European Journal of Heart Failure ·Stephan von Haehling, Dirk J. van Veldhuisen, Sy Ha, Daphne Babalis, Rudolf A. de Boer, Andrew J.S. Coats, Luís Manzano, Marcus Flather, Stefan D. Anker
50
14
Predictors of Clinical Outcomes in Elderly Patients with Heart Failure
2011 ·European Journal of Heart Failure ·Luís Manzano, Daphne Babalis, Sy Ha, Marcelo C. Shibata, Stefan D. Anker, Stefano Ghio, Dirk J. van Veldhuisen, Alain Cohen‐Solal, Andrew J.S. Coats, Philip Poole-Wilson, Marcus Flather
94
15
Exercise Training for Systolic Heart Failure: Cochrane Systematic Review and Meta-Analysis
2010 ·European Journal of Heart Failure ·Edward J. Davies, T Moxham, Karen Rees, Sally J Singh, Andrew J.S. Coats, Shah Ebrahim, Fiona Lough, Rod S Taylor
228
16
Heart Transplantation in Heart Failure: The Prognostic Importance of Body Mass Index at Time of Surgery and Subsequent Weight Changes
2007 ·European Journal of Heart Failure ·Andrew L. Clark, Christoph Knosalla, Emma J. Birks, Matthias Loebe, Constantinos H. Davos, Sui Tsang, Abdissa Negassa, Magdi H. Yacoub, Roland Hetzer, Andrew J.S. Coats, Stefan D. Anker
28
17
The anti-CD14 Antibody IC14 Suppresses Ex Vivo Endotoxin Stimulated Tumor Necrosis Factor-Alpha in Patients with Chronic Heart Failure
2005 ·European Journal of Heart Failure ·Sabine Genth‐Zotz, Stephan von Haehling, Aidan P. Bolger, Paul R. Kalra, Roland Wensel, Andrew J.S. Coats, Hans‐Dieter Volk, Stefan D. Anker
21
18
Whole Blood Endotoxin Responsiveness in Patients with Chronic Heart Failure: The Importance of Serum Lipoproteins
2005 ·European Journal of Heart Failure ·Rakesh Kumar Sharma, Stephan von Haehling, Mathias Rauchhaus, Aidan P. Bolger, Sabine Genth‐Zotz, Wolfram Doehner, Brian G. Oliver, Philip A. Poole‐Wilson, Hans‐Dieter Volk, Andrew J.S. Coats, Ian M. Adcock, Stefan D. Anker
43
19
Exercise Training in Chronic Heart Failure: Effects on Pro-Inflammatory Markers
2004 ·European Journal of Heart Failure ·Josef Niebauer, Andrew L. Clark, (unknown), Andrew J.S. Coats
56
20
Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH) breakdown →
2004 ·BMJ ·Massimo Piepoli, Constantinos H. Davos, Dárrel P. Francis, Andrew J.S. Coats
676

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppe Mancia Breakdown of academic impact, for papers by Piotr Ponikowski Breakdown of academic impact, for papers by Dalane W. Kitzman Breakdown of academic impact, for papers by Jay N. Cohn Breakdown of academic impact, for papers by Milton Packer Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by William T. Abraham Breakdown of academic impact, for papers by Stefan D. Anker Breakdown of academic impact, for papers by Margaret M. Redfield Breakdown of academic impact, for papers by Gianfranco Parati
Rankless by CCL
2026